Marshall Urist

Insider Reports History

Location
C/O Royalty Pharma Plc, 110 East 59 Th Street, New York, NY
Signature
/s/ Sean Weisberg, as Attorney-in-Fact, for Marshall Urist
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Marshall Urist:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Royalty Pharma plc EVP, Research & Investments Class A Ordinary Shares 46.7K $1.55M $33.15 Aug 6, 2025 By Sandy Lamm LLC
Royalty Pharma plc EVP, Research & Investments Class A Ordinary Shares 39.3K $1.3M $33.15 Aug 6, 2025 Direct
Royalty Pharma plc EVP, Research & Investments Class A Ordinary Shares 19K $631K $33.15 Aug 6, 2025 By IRA
Royalty Pharma plc EVP, Research & Investments Class E Ordinary Shares 1.36M May 16, 2025 Indirect
Royalty Pharma plc EVP, Research & Investments LP interests in RPI US Partners 2019, LP 263K Aug 8, 2025 By Sandy Lamm LLC

Insider Reports Filed by Marshall Urist

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RPRX Royalty Pharma plc Aug 6, 2025 2 $0 4 Aug 8, 2025 EVP, Research & Investments
RPRX Royalty Pharma plc May 16, 2025 1 $0 4 May 20, 2025 EVP, Research & Investments
RPRX Royalty Pharma plc May 8, 2025 1 $0 4 May 9, 2025 EVP, Research & Investments
RPRX Royalty Pharma plc Aug 12, 2024 1 $0 4 Aug 12, 2024 EVP, Research & Investments
RPRX Royalty Pharma plc Feb 22, 2023 1 -$870K 4 Feb 24, 2023 EVP, Research & Investments
RPRX Royalty Pharma plc Feb 17, 2023 2 $0 4 Feb 17, 2023 EVP, Research & Investments
RPRX Royalty Pharma plc Jul 25, 2022 2 -$1.01M 4 Jul 27, 2022 EVP, Research & Investments
RPRX Royalty Pharma plc Jun 24, 2022 1 -$1.01M 4 Jun 24, 2022 EVP, Research & Investments
RPRX Royalty Pharma plc May 16, 2022 1 -$930K 4 May 16, 2022 EVP, Research & Investments
RPRX Royalty Pharma plc May 11, 2022 2 $0 4 May 11, 2022 EVP, Research & Investments
RPRX Royalty Pharma plc Jun 4, 2021 2 -$1.53M 4 Jun 8, 2021 EVP & Co-Head of R&I
RPRX Royalty Pharma plc Jun 2, 2021 1 -$605K 4 Jun 4, 2021 EVP & Co-Head Research & Inv.
RPRX Royalty Pharma plc May 20, 2021 2 -$82.2K 4 May 24, 2021 EVP & Co-Head Research & Inv.
RPRX Royalty Pharma plc May 7, 2021 2 $0 4 May 11, 2021 EVP & Co-Head Research & Inv.